Hermetica Superfood Encyclopedia
The Short Answer
Dunaliella tertiolecta produces alpha-tocopherol—the most biologically active form of Vitamin E—which integrates into lipid membranes to scavenge reactive oxygen species (ROS) and inhibit lipid peroxidation, protecting cells from oxidative damage. Alpha-tocopherol concentrations in D. tertiolecta biomass reach up to 1.90 mg/g dry weight, among the highest recorded in microalgae, though human clinical evidence for this specific algal source remains limited to in vitro antiproliferative studies.
CategoryVitamin
GroupMarine-Derived
Evidence LevelPreliminary
Primary KeywordDunaliella tertiolecta vitamin E benefits
Dunaliella tertiolecta Vitamin E — botanical close-up
Health Benefits
**Cellular Antioxidant Protection**
Alpha-tocopherol integrates into phospholipid bilayers and quenches lipid peroxyl radicals via hydrogen donation, interrupting chain-reaction oxidative damage to cell membranes and organelles.
**Photooxidative Stress Defense**: In D
tertiolecta's native biology, alpha-tocopherol prevents photosystem II (PSII) inactivation under high-light conditions by scavenging singlet oxygen and superoxide generated during photoinhibition, a mechanism translatable to protecting mammalian cells under UV or oxidative stress.
**Antiproliferative Activity (In Vitro)**: Extracts of D
tertiolecta containing Vitamin E, xanthophyll, and violaxanthin demonstrated antiproliferative effects against cancer cell lines in vitro (Pasquet et al., 2011), suggesting a synergistic antioxidant-carotenoid mechanism, though human confirmation is absent.
**Lipid Peroxidation Inhibition**
Alpha-tocopherol's tocopherol head group donates a phenolic hydrogen to neutralize polyunsaturated fatty acid-derived peroxyl radicals, reducing malondialdehyde formation and preserving membrane integrity—relevant to cardiovascular and neurological health.
**Immune Modulation Support**
General alpha-tocopherol research demonstrates enhancement of T-lymphocyte proliferation and natural killer cell activity at physiological concentrations, effects attributable to the same alpha-tocopherol molecule present in D. tertiolecta biomass.
**Complementary Carotenoid Synergy**
The co-presence of β-carotene, violaxanthin, and xanthophylls alongside Vitamin E in D. tertiolecta biomass creates a multi-antioxidant matrix that may provide broader ROS quenching than isolated alpha-tocopherol alone, as xanthophylls operate in distinct membrane compartments.
**Potential Neuroprotective Effects**
Alpha-tocopherol is the predominant Vitamin E form in brain tissue, where it protects neuronal membranes from oxidative degradation; while no D. tertiolecta-specific neurology studies exist, the bioactive compound is structurally and functionally identical to that used in neuroprotection research.
Origin & History
Natural habitat
Dunaliella tertiolecta is a unicellular, halotolerant green microalga native to marine and hypersaline aquatic environments worldwide, including coastal seawater, salt lakes, and estuaries. It thrives across a broad salinity range and is commercially cultivated in photobioreactors and open raceway ponds under controlled light and nutrient conditions to maximize its antioxidant output. Unlike terrestrial Vitamin E sources, this organism biosynthesizes alpha-tocopherol as part of its photoprotective strategy, with production yields modulated by light intensity, nitrogen source, and culture density.
“Dunaliella tertiolecta has no documented history of traditional medicinal or dietary use in any ethnobotanical or ethnopharmacological record, as its characterization as a distinct microalgal species and its biochemical exploitation are entirely products of modern marine biotechnology. The genus Dunaliella gained scientific attention in the mid-20th century primarily through Dunaliella salina, harvested for its extraordinary beta-carotene yields in hypersaline systems such as those in Australia and Israel, establishing the genus as a model for algal antioxidant production. D. tertiolecta emerged as a research organism in marine phycology during the latter decades of the 20th century, valued for its robustness in temperate marine culture conditions and its amenability to laboratory cultivation rather than traditional human use. Its Vitamin E content was identified as a secondary research finding within studies primarily focused on photosynthesis, pigment biochemistry, and polyunsaturated fatty acid production, positioning it firmly as a biotechnological ingredient rather than a culturally or historically grounded remedy.”Traditional Medicine
Scientific Research
The scientific evidence base for D. tertiolecta as a Vitamin E source is currently confined to algal biotechnology and in vitro pharmacology, with no published human clinical trials specifically examining this microalgal extract. Production studies (e.g., Carballo-Cárdenas et al. and related batch culture investigations) have quantified alpha-tocopherol yields up to 1.90 mg/g DW under optimized light and nitrogen conditions, establishing its commercial viability. Pasquet et al. (2011) documented antiproliferative activity of D. tertiolecta extracts—attributed to its Vitamin E, xanthophyll, and violaxanthin content—against human cancer cell lines in vitro, but without dose-response quantification translatable to human supplementation. The broader alpha-tocopherol literature includes extensive human trial data from other sources (e.g., ATBC Trial, HOPE trial), but these cannot be directly extrapolated to this algal-specific extract without dedicated bioavailability and pharmacokinetic studies.
Preparation & Dosage
Traditional preparation
**Microalgal Biomass (Dried Powder)**
90 mg/g DW means significant biomass quantities would be required to reach general adult adequate intake (15 mg/day alpha-tocopherol per NIH guidelines)
No established human dose; alpha-tocopherol content of up to 1..
**Lipid Extract (Alpha-Tocopherol Concentrate)**
Typically produced via solvent extraction (hexane or ethanol) of lyophilized D. tertiolecta biomass; no standardized commercial supplement form currently exists.
**Culture Optimization for Maximum Yield**
High-density batch cultures under light-limited conditions (reduced photons per cell) and nitrogen-supplemented media maximize alpha-tocopherol accumulation during linear and stationary growth phases.
**Timing (General Alpha-Tocopherol Guidance)**
Fat-soluble nature requires co-administration with dietary fat for optimal intestinal absorption; best taken with meals containing lipids.
**Standardization**
No industry standardization percentage exists for D. tertiolecta Vitamin E supplements; general Vitamin E supplements are typically standardized to d-alpha-tocopherol content (IU or mg).
**Tolerable Upper Intake Level (General Alpha-Tocopherol)**
000 mg/day of supplemental alpha-tocopherol as the UL for adults; this threshold is extrapolated from other sources and has not been confirmed for the algal form
The NIH establishes 1,.
Nutritional Profile
D. tertiolecta biomass is nutritionally complex beyond its Vitamin E content, with alpha-tocopherol as the dominant tocopherol isomer at up to 1.90 mg/g DW—a concentration exceeding many common dietary sources on a per-gram basis. Co-occurring antioxidants include β-carotene (a provitamin A carotenoid), ascorbic acid (Vitamin C), violaxanthin, and xanthophylls, which collectively create a multi-layered antioxidant matrix within the biomass. The alga also contains omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), particularly in its membrane lipids, which are themselves the primary substrate protected by alpha-tocopherol from peroxidation. Protein content typical of green microalgae ranges from 10–30% DW, alongside carbohydrates and pigment-protein complexes; however, precise macronutrient values for D. tertiolecta vary substantially by culture condition and growth phase. Bioavailability of alpha-tocopherol from whole algal biomass may differ from isolated forms due to cell wall encapsulation (requiring processing or digestion to release lipid-soluble contents) and the presence of bioavailability-enhancing co-factors such as lipids and carotenoids.
How It Works
Mechanism of Action
Alpha-tocopherol derived from D. tertiolecta functions as a chain-breaking antioxidant by donating a hydrogen atom from its phenolic hydroxyl group to lipid peroxyl radicals (LOO•), generating a relatively stable tocopheroxyl radical that is subsequently recycled by ascorbic acid (Vitamin C) or glutathione—a regeneration cycle that extends its protective activity within lipid bilayers. At the molecular level, alpha-tocopherol suppresses phospholipase A2 activity and modulates protein kinase C (PKC) signaling, reducing arachidonic acid release and downstream pro-inflammatory eicosanoid synthesis. Within the algal system, it acts in concert with the xanthophyll cycle—particularly violaxanthin de-epoxidation to zeaxanthin—to dissipate excess excitation energy and prevent singlet oxygen accumulation at photosystem II reaction centers, a mechanism that parallels its protective role in mammalian mitochondrial electron transport chains. Gene-level effects of alpha-tocopherol include upregulation of antioxidant response element (ARE)-driven genes via Nrf2 pathway activation, suppressing NF-κB-mediated inflammatory transcription at higher concentrations.
Clinical Evidence
No clinical trials have been conducted using Vitamin E specifically isolated from Dunaliella tertiolecta as an intervention in human subjects, representing a significant gap in the translational research pipeline for this ingredient. In vitro evidence from Pasquet et al. (2011) indicates antiproliferative effects of whole D. tertiolecta extracts, but sample sizes, effect sizes, and mechanistic attribution to alpha-tocopherol versus co-occurring carotenoids were not clearly delineated. The clinical profile of alpha-tocopherol as a compound is well-established across decades of human research involving cardiovascular disease, immune function, and neuroprotection, but source-specific bioequivalence for microalgal alpha-tocopherol has not been established in pharmacokinetic studies. Consequently, confidence in clinical outcomes attributable specifically to D. tertiolecta Vitamin E remains very low, and this ingredient should be regarded as preclinical from a human health standpoint.
Safety & Interactions
No specific adverse events, toxicological data, or drug interaction profiles have been reported for Vitamin E derived specifically from Dunaliella tertiolecta, and no regulatory safety assessment for this algal source exists in major pharmacopoeias or food safety databases. Safety assumptions are currently extrapolated from the well-characterized profile of alpha-tocopherol generally: at dietary intake levels (up to 15 mg/day for adults), alpha-tocopherol is considered safe, but supplemental doses exceeding 400–1,000 mg/day have been associated with increased bleeding risk due to antagonism of Vitamin K-dependent coagulation factors, warranting caution in patients on warfarin or other anticoagulants. As a microalgal supplement, D. tertiolecta biomass carries class-level risks common to algae products, including potential heavy metal contamination (arsenic, lead, cadmium) if cultivation water quality is not rigorously controlled, and possible allergic reactions in individuals sensitized to marine organisms. Pregnancy and lactation guidance defaults to general alpha-tocopherol recommendations (adequate intake of 15–19 mg/day); high-dose supplementation from any source during pregnancy should be avoided without medical supervision, and algae-derived supplements during pregnancy or breastfeeding have insufficient safety data to support unrestricted use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Dunaliella tertiolectaD. tertiolecta alpha-tocopherolmarine microalgal Vitamin Ealgal tocopherolDunaliella Vitamin E extract
Frequently Asked Questions
What form of Vitamin E does Dunaliella tertiolecta produce?
Dunaliella tertiolecta primarily produces alpha-tocopherol, the most biologically active and bioavailable form of Vitamin E in humans. This lipid-soluble molecule is synthesized by the alga as part of its photoprotective antioxidant system, reaching concentrations of up to 1.90 mg per gram of dry biomass under optimized culture conditions.
Is there clinical evidence that Vitamin E from Dunaliella tertiolecta works in humans?
No human clinical trials have been conducted specifically using Vitamin E extracted from Dunaliella tertiolecta. Current evidence is limited to in vitro studies, such as Pasquet et al. (2011), which showed antiproliferative effects of D. tertiolecta extracts (containing Vitamin E, xanthophyll, and violaxanthin) against cancer cell lines, and to algal production biochemistry research. Human bioavailability and efficacy data are not yet available for this specific source.
How does Vitamin E from D. tertiolecta compare to plant-derived Vitamin E?
The alpha-tocopherol molecule produced by D. tertiolecta is chemically identical to that found in plant oils such as wheat germ, sunflower, and soybean oil, meaning its antioxidant mechanism of action is the same. D. tertiolecta can accumulate up to 1.90 mg/g DW of alpha-tocopherol, which is competitive with many plant sources on a dry-weight basis; however, no human pharmacokinetic studies have confirmed whether bioavailability from algal biomass matches that from conventional food or supplement sources.
What are the safety concerns with taking Dunaliella tertiolecta Vitamin E supplements?
No unique toxicity has been documented for D. tertiolecta-derived Vitamin E, but general concerns apply: high-dose alpha-tocopherol supplementation (above 400–1,000 mg/day) may increase bleeding risk, particularly in individuals taking warfarin or antiplatelet medications. Additionally, as an algae-derived product, unregulated D. tertiolecta biomass could carry heavy metal contamination risks if cultivation water is not properly monitored, and quality-controlled commercial products are not yet widely established.
Can Dunaliella tertiolecta Vitamin E be used for antioxidant supplementation?
Dunaliella tertiolecta represents a theoretically viable biotechnological source of alpha-tocopherol with antioxidant potential comparable to conventional Vitamin E, but it currently lacks established supplemental dosing guidelines, commercial standardization, and human clinical validation. Until dedicated bioavailability and efficacy trials are completed, its use as a standalone antioxidant supplement cannot be clinically recommended, and it is more accurately characterized as an emerging ingredient in algal biotechnology rather than an established nutraceutical.
How does Dunaliella tertiolecta Vitamin E protect against photooxidative stress?
Vitamin E (alpha-tocopherol) from Dunaliella tertiolecta prevents photosystem II inactivation under high-light conditions, a defense mechanism the microalga naturally employs in its aquatic environment. This same protective mechanism may help shield human cells from oxidative damage caused by environmental stressors like UV exposure and pollution. The alpha-tocopherol integrates into cell membranes where it quenches lipid peroxyl radicals through hydrogen donation, interrupting chain-reaction oxidative damage to cellular structures.
Who benefits most from Dunaliella tertiolecta Vitamin E supplementation?
Individuals with high oxidative stress exposure—such as athletes, those with inflammatory conditions, or people in high-pollution environments—may benefit most from Dunaliella tertiolecta Vitamin E due to its direct integration into cell membranes and lipid structures. Those seeking whole-food microalgae sources rather than synthetic or plant-derived forms may also prefer this ingredient for its naturally concentrated alpha-tocopherol content. People with compromised antioxidant defenses or those unable to obtain adequate Vitamin E from dietary sources are additional candidates for supplementation.
What makes Dunaliella tertiolecta a unique source of Vitamin E compared to synthetic production methods?
Dunaliella tertiolecta produces Vitamin E (alpha-tocopherol) through biological synthesis within living microalgal cells, avoiding synthetic chemical manufacturing and resulting in a naturally bioavailable form. The microalga concentrates alpha-tocopherol as part of its own photoprotective strategy, potentially offering a metabolically optimized form for human absorption. This whole-food microalgae source may provide additional phytonutrients and cofactors naturally present in the organism, though Vitamin E remains the primary active compound.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w vitamin-e-from-dunaliella-tertiolecta-dunaliella-tertiolecta-microalgae curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
